Hawaii Biotech, Inc.

34 articles about Hawaii Biotech, Inc.

• Hawaii Biotech President And CEO Elliot Parks Stepping Down

  6/7/2021

  Hawaii Biotech, Inc., a privately held technology company that develops vaccines and biodefense drugs, announced that Elliot Parks, Ph.D., president and chief executive officer, is retiring for medical reasons.

• HAWAII BIOTECH AWARDED $38.5 MILLION FOR CONTINUED DEVELOPMENT OF ANTI-TOXIN DRUG TO TREAT ANTHRAX IN HUMANS

  11/1/2018

  Hawaii Biotech Inc. will continue its development of an anti-toxin drug for anthrax in humans with a recently awarded contract from the National Institute of Allergy and Infectious Diseases (NIAID), a federal government agency.

• 

  Mosquitoes Will Rule the Earth as Climate Change Expands Disease Vectors

  9/26/2018

  Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.

• Hawaii Biotech, Inc. To Develop Ebola Vaccine With University of Hawaii

  9/27/2017

• Hawaii Biotech, Inc. Awarded Grant To Develop Chikungunya Virus Vaccine

  8/30/2016

• Hawaii Biotech, Inc. Receives Contract To Develop Dengue Vaccine

  12/7/2015

• Hawaii Biotech, Inc. Adds Drug Discovery To Vaccine Development

  3/5/2014

• Hawaii Biotech, Inc. Gains Rights to West Nile Vaccine Technology From Merck & Co., Inc.

  4/11/2013

• Hawaii Biotech, Inc. Licenses Vaccine Technology from Merck & Co., Inc.

  11/1/2011

• Hawaii Biotech, Inc. Exits Bankruptcy

  6/21/2011

• Merck & Co., Inc. Acquires Part of Bankrupt Hawaii Biotech, Inc.

  7/22/2010

• Advanced BioScience Laboratories, Inc. to Manufacture Hawaii Biotech, Inc.'s Dengue Vaccine for Clinical Trial

  5/25/2010

• Hawaii Biotech, Inc. Completes Dosing of Phase 1 Trial for Dengue Virus Monovalent Vaccine

  1/7/2010

• Hawaii Biotech, Inc. Files for Bankruptcy

  12/15/2009

• Hawaii Biotech, Inc. Initiates Phase 1 Clinical Trial for Dengue Vaccine

  8/25/2009

• Hawaii Biotech, Inc. Receives Tick-Borne Encephalitis Vaccine Grant

  8/11/2009

• Michael Spooner Appointed To The Hawaii Biotech Board

  7/27/2009

• Hawaii Biotech, Inc. Reports Phase 1 Results for West Nile Virus Vaccine

  2/25/2009

• Cobra BioManufacturing Release: Hawaii Biotech, Inc. Finishes Phase I West Nile Clinical Trial

  1/20/2009

• Hawaii Biotech, Inc. Completes Dosing of Phase 1 Trial for West Nile Virus Vaccine

  12/15/2008